Congenital heart disease symptomatic
Conditions
Interventions
Patients in the intervention group will be monitored for 24 months. The mHealth
telemonitoring program will be used in addition to usual care. The mHealth
telemonitoring program will monitor body we
Sponsors
Academisch Medisch Centrum
Eligibility
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: > 18 years Congenital heart disease patient Symptomatic in the last 1 year: Heart failure NYHA class * II, palpitations or arrhythmias, hypertension. Patients with a genetic abnormality resulting in an altered cardiac anatomy or function.
Exclusion criteria
Exclusion criteria: Unable to give informed consent Tremor Not in possession of smart phone or personal computer
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary research question is to assess the effect of mHealth-based monitoring on the number of contact moments with the hospital (i.e. contact with the outpatient clinic (visits and telephone consults), visits to the emergency department, and hospitalizations), in comparison with the control group. | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary research questions are superiority of health-related quality of life, as measured with the EuroQol-5D-5L, SF-36 and PAM-13 using the mHealth intervention in comparison with the control group and the number of contact moments, outpatient clinic visits, ER visits and emergency admissions. Research questions on cost effectiveness are whether a mHealth-based monitoring pathway leads to cost reduction through change in the number of contact moments with the hospital (i.e. contact with the outpatient clinic (visits and telephone consults), visits to the emergency department, and hospitalizations), in comparison with the control group. | — |
Countries
Netherlands
Outcome results
None listed